BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 17532308)

  • 1. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
    Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
    Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities.
    Bryk B; BenMoyal-Segal L; Podoly E; Livnah O; Eisenkraft A; Luria S; Cohen A; Yehezkelli Y; Hourvitz A; Soreq H
    J Neurochem; 2005 Mar; 92(5):1216-27. PubMed ID: 15715671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides.
    López-Flores I; Lacasaña M; Blanco-Muñoz J; Aguilar-Garduño C; Sanchez-Villegas P; Pérez-Méndez OA; Gamboa-Avila R
    Toxicol Lett; 2009 Jul; 188(2):84-90. PubMed ID: 19446239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase-1 genetic polymorphisms and susceptibility to DNA damage in workers occupationally exposed to organophosphate pesticides.
    Singh S; Kumar V; Thakur S; Banerjee BD; Rautela RS; Grover SS; Rawat DS; Pasha ST; Jain SK; Ichhpujani RL; Rai A
    Toxicol Appl Pharmacol; 2011 Apr; 252(2):130-7. PubMed ID: 21291901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase status and plasma butyrylcholinesterase activity in chlorpyrifos manufacturing workers.
    Albers JW; Garabrant DH; Berent S; Richardson RJ
    J Expo Sci Environ Epidemiol; 2010 Jan; 20(1):79-89. PubMed ID: 19223938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of paraoxonase 1 192 Q/R polymorphism on paraoxonase and acetylcholinesterase enzyme activities in a Turkish population exposed to organophosphate.
    Sunay SZ; Kayaaltı Z; Bayrak T; Söylemezoğlu T
    Toxicol Ind Health; 2015 Dec; 31(12):1061-8. PubMed ID: 23625910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms and activity of PON1 in a Mexican population.
    Rojas-García AE; Solís-Heredia MJ; Piña-Guzmán B; Vega L; López-Carrillo L; Quintanilla-Vega B
    Toxicol Appl Pharmacol; 2005 Jun; 205(3):282-9. PubMed ID: 15922013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis.
    Morahan JM; Yu B; Trent RJ; Pamphlett R
    Neurotoxicology; 2007 May; 28(3):532-40. PubMed ID: 17204329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal exposure to floricultural work during pregnancy, PON1 Q192R polymorphisms and the risk of low birth weight.
    Moreno-Banda G; Blanco-Muñoz J; Lacasaña M; Rothenberg SJ; Aguilar-Garduño C; Gamboa R; Pérez-Méndez O
    Sci Total Environ; 2009 Oct; 407(21):5478-85. PubMed ID: 19646734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of pon1 and pon2 genes in hemodialyzed patients.
    Rajković MG; Barišić K; Juretić D; Grubišić TŽ; Flegar-Meštrić Z; Rumora L
    Clin Biochem; 2011 Aug; 44(12):964-8. PubMed ID: 21620813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of paraoxonase 192/55 polymorphism in an Iranian population.
    Sepahvand F; Rahimi-Moghaddam P; Shafiei M; Ghaffari SM; Rostam-Shirazi M; Mahmoudian M
    J Toxicol Environ Health A; 2007 Jul; 70(13):1125-9. PubMed ID: 17558807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
    Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
    Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
    Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
    Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
    Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH
    Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplotype-phenotype relationships of paraoxonase-1.
    Chen J; Chan W; Wallenstein S; Berkowitz G; Wetmur JG
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):731-4. PubMed ID: 15767359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of paraoxonase-1 gene polymorphisms and enzyme activity in a Peruvian population.
    Cataño HC; Cueva JL; Cardenas AM; Izaguirre V; Zavaleta AI; Carranza E; Hernández AF
    Environ Mol Mutagen; 2006 Dec; 47(9):699-706. PubMed ID: 17078098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity and determinants of cholinesterases and paraoxonase-1 in blood of workers exposed to non-cholinesterase inhibiting pesticides.
    Lozano-Paniagua D; Gómez-Martín A; Gil F; Parrón T; Alarcón R; Requena M; Lacasaña M; Hernández AF
    Chem Biol Interact; 2016 Nov; 259(Pt B):160-167. PubMed ID: 27062891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PON1 activity and genotype in patients with arterial ischemic stroke and in healthy individuals.
    Schiavon R; Turazzini M; De Fanti E; Battaglia P; Targa L; Del Colle R; Fasolin A; Silvestri M; Biasioli S; Guidi G
    Acta Neurol Scand; 2007 Jul; 116(1):26-30. PubMed ID: 17587252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.
    Kovács TJ; Harris S; Vas TK; Seres I; Short CD; Wittmann IK; Paragh G; Mackness MI; Mackness B; Durrington PN; Nagy JM; Brenchley PE
    J Nephrol; 2006; 19(6):732-8. PubMed ID: 17173245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.